MANCHESTER, U.K. – Tocilizumab showed signs of improving skin and other symptoms in patients with systemic sclerosis (SSc) in an ongoing proof-of-co... More »
Field of Interest: Dermatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.